Multimodality vendor GE Medical Systems and Agfa-Gevaert have joined forces in an alliance for sales of computed radiography systems, the companies announced this month. The three-year agreement stipulates that Waukesha, WI-based GE will market, sell,
Multimodality vendor GE Medical Systems and Agfa-Gevaert have joined forces in an alliance for sales of computed radiography systems, the companies announced this month. The three-year agreement stipulates that Waukesha, WI-based GE will market, sell, and service Agfa Diagnostic Center (ADC) Compact and Solo CR systems under the GE label worldwide. Both systems feature Agfas Musica image processing software.
With access to GEs large sales force and widespread installed base of x-ray systems, the deal boosts Agfas reach into markets around the world and gives it an opportunity to expand its CR business, according to the Mortsel, Belgium-based company.
GE moves closer to its goal of providing its customers with tools to transition into a completely digital environment. Agfa replaces Fuji Medical Systems USA as GEs CR supplier. Fuji had signed a similar deal with GE in 1995 (SCAN 8/30/95). At the time, the agreement represented Fujis first OEM deal for its CR readers.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.